ARS Pharmaceuticals (SPRY) Inventory (2024 - 2026)

ARS Pharmaceuticals' Inventory history runs 3 years deep, the most recent figure standing at $8.8 million for Q1 2026.

• In Q1 2026, Inventory rose 21.28% year-over-year to $8.8 million; the TTM figure through Mar 2026 stood at $8.8 million (up 21.28% YoY), while the FY2025 annual figure was $8.4 million, up 60.57% from the prior year.
• Inventory came in at $8.8 million for Q1 2026 at ARS Pharmaceuticals, up from $8.4 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $8.8 million in Q1 2026 to a low of $715000.0 in Q3 2024.
• A 3-year average of $6.7 million and a median of $7.8 million in 2025 frame the typical range for Inventory.
• Across the five-year window, Inventory soared 988.39% in 2025 and increased 21.28% in 2026, its largest moves.
• ARS Pharmaceuticals' Inventory stood at $5.2 million in 2024, then soared by 60.57% to $8.4 million in 2025, then increased by 5.35% to $8.8 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $8.8 million, $8.4 million, and $7.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison